Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease
about
Can physical exercise in old age improve memory and hippocampal function?Control of the Normal and Pathological Development of Neural Stem and Progenitor Cells by the PC3/Tis21/Btg2 and Btg1 GenesEffects of chronic fluoxetine treatment on neurogenesis and tryptophan hydroxylase expression in adolescent and adult ratsEffects of Neurotrophic Support and Amyloid-Targeted Combined Therapy on Adult Hippocampal Neurogenesis in a Transgenic Model of Alzheimer's DiseaseMad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsSex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.Fluoxetine attenuates the impairment of spatial learning ability and prevents neuron loss in middle-aged APPswe/PSEN1dE9 double transgenic Alzheimer's disease mice.Temporal dynamics of hippocampal neurogenesis in chronic neurodegeneration.Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.Genetic manipulation of adult-born hippocampal neurons rescues memory in a mouse model of Alzheimer's disease.NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases.Amyloid β Is Not the Major Factor Accounting for Impaired Adult Hippocampal Neurogenesis in Mice Overexpressing Amyloid Precursor ProteinPhysical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse modelCognitive reserve and Alzheimer's disease.Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.On the Run for Hippocampal Plasticity.The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age.Limited Effects of Prolonged Environmental Enrichment on the Pathology of 5XFAD Mice.Dual roles of Aβ in proliferative processes in an amyloidogenic model of Alzheimer's diseaseFluoxetine effects on molecular, cellular and behavioral endophenotypes of depression are driven by the living environmentCognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.Environmental Enrichment Duration Differentially Affects Behavior and Neuroplasticity in Adult Mice.Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells.Citalopram attenuates tau hyperphosphorylation and spatial memory deficit induced by social isolation rearing in middle-aged rats.How can we exploit the brain's ability to repair itself?Long-term Ameliorative Effects of the Antidepressant Fluoxetine Exposure on Cognitive Deficits in 3 × TgAD Mice.Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice.Altered neurogenesis in mouse models of Alzheimer disease.Targeting glucocorticoid receptors prevents the effects of early life stress on amyloid pathology and cognitive performance in APP/PS1 mice.RNA-Sequencing Reveals Unique Transcriptional Signatures of Running and Running-Independent Environmental Enrichment in the Adult Mouse Dentate Gyrus.How the Body Talks to the Brain; Peripheral Mediators of Physical Activity-Induced Proliferation in the Adult Hippocampus.
P2860
Q26766517-72788C74-A896-4DB0-A8F3-1C1124CC409AQ28261895-D39FF1A5-8909-4F7F-AA57-89D944E33477Q28538828-479F8058-558A-4896-86A8-5BB9F6B60856Q28552895-9931F99B-CAD9-43D8-BE26-3F537781082CQ30364736-470C5591-3461-485D-B020-86C0686138C3Q30407853-4B9F6DB5-BBA2-44E8-8E34-034CCDFB6DC0Q33709399-59859137-E0BF-4D2A-B33D-631A4FD2A1CDQ33937526-928B4108-BEC5-42F3-92BF-64B6A608263BQ34794030-E2D31575-99AE-412B-B59A-31BC33ACFF64Q35527668-32C3F240-3ED0-4FF3-8FFE-D7BACCD499A8Q35811161-245FB8E6-76ED-4B74-99A3-F00A7A51D085Q37338122-B1D43B83-77DD-475D-AE92-C7AE60F5FA3CQ37349907-B131AA7C-B975-4F89-821B-920FAF944FCEQ38209190-68097EE8-EE73-445A-9554-9ABF50F10D2BQ38263685-A1970807-E52D-4394-83CD-9A7D7100F979Q38403023-D78A6F7B-968A-4A11-AE3A-B2C438A7CBF8Q38783891-DFFC85D1-BBFF-431B-954B-B2A2F6A84931Q39297069-2AEB8E0B-A99D-4B7D-9092-2CEB0ED3A3D5Q41565896-A4433EE1-C67F-498A-B520-FD13D9A2F37CQ42292947-34759BA4-8366-400D-89E4-7867DFD935A0Q47110701-FE480923-2182-4A87-A2AE-10B9C6D1B170Q47762261-2E57BFF8-982F-44EE-A04E-D3811D25E34CQ48114156-119052ED-36B4-4567-AEAA-51F9D75BF875Q48158214-97F86240-ECB2-4191-B5A2-31B0ED31A030Q48169500-E510E34D-F41E-474C-966A-D70B08826EEEQ48664940-8531FCCE-40EE-4B14-97B0-59547A8C8544Q50541378-3B7B9C92-7C39-4599-8C1D-CCD6D517053EQ52725068-3DC9B166-BCE7-46E1-B298-4F90687257BDQ53081269-BA7D13BC-1C7E-4C54-BF8C-C3C4B61C8149Q54938323-F6DAD346-939A-445E-A74C-6E92831805ABQ55175005-3C5BEBBA-3258-415D-981F-B085D7217228
P2860
Prolonged running, not fluoxetine treatment, increases neurogenesis, but does not alter neuropathology, in the 3xTg mouse model of Alzheimer's disease
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Prolonged running, not fluoxet ...... e model of Alzheimer's disease
@ast
Prolonged running, not fluoxet ...... e model of Alzheimer's disease
@en
type
label
Prolonged running, not fluoxet ...... e model of Alzheimer's disease
@ast
Prolonged running, not fluoxet ...... e model of Alzheimer's disease
@en
prefLabel
Prolonged running, not fluoxet ...... e model of Alzheimer's disease
@ast
Prolonged running, not fluoxet ...... e model of Alzheimer's disease
@en
P2093
P2860
P356
P1476
Prolonged running, not fluoxet ...... e model of Alzheimer's disease
@en
P2093
Henriette van Praag
Michael W Marlatt
Michelle C Potter
Paul J Lucassen
Thomas A Bayer
P2860
P304
P356
10.1007/7854_2012_237
P577
2013-01-01T00:00:00Z